Ketogenic dietary therapy in adolescents and adults with medically intractable epilepsy: survey, patient education, and non-interventional observation

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023641

Enrollment

Registered

2020-12-04

Start date

2020-11-02

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G40

Interventions

Group 1: In patients with pharmacoresistant epilepsy, treatment data are collected, pseudonymized and evaluated before the start of ketogenic therapy and during the follow-up or final visits after a p

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: confirmed diagnosis of epilepsy, pharmacoresistance, age: > 15 years, voluntary participation with the written consent of patients or legal guardians

Exclusion criteria

Exclusion criteria: age < 16 years, medical contraindications

Design outcomes

Primary

Measure	Time frame
retention	—

Secondary

Measure	Time frame
seizure control and tolerability; Questionnaire on knowledge and attitude regarding KET; Questionnaire for the evaluation of the training program	—

Countries

Germany

Contacts

Public ContactMartin Lutz

Epilepsiezentrum Kleinwachau

m.lutz@kleinwachau.de035284311313

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026